Dick de Zeeuw

Also affiliated with University of Groningen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

9.9Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

New England Journal of Medicine(2017)10.1056/nejmoa1611925

Top 1%

9.9DataRank

Top 1%7805 citations

Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu +5 more

Papers

Driven by 17 papers — median percentile 99. Top paper: “Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes”.

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

New England Journal of Medicine(2017)10.1056/nejmoa1611925

Top 1%

9.9DataRank

Top 1%7805 citations

Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu +5 more

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Stroke(2021)10.1161/strokeaha.120.031623

N/A

3.6DataRank · unranked

120 citations

Meg Jardine, Qiang Li, Brendon L. Neuen, Christopher P. Cannon, Dick de Zeeuw +95 more

Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.15260920

N/A

3.4DataRank · unranked

54 citations

Zien Zhou, Hiddo J.L. Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal +18 more

Nephroptosis and Kidney Function

Nephron(2008)10.1159/000181477

N/A

2.0DataRank · unranked

13 citations

A.J.M. Donker, Gerard van Herk, Els Kremer, Dick de Zeeuw

Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.08780621

N/A

1.4DataRank · unranked

48 citations

Taha Sen, Clare Arnott, Bruce Neal, Jos G. W. Kosterink, Kenneth W. Mahaffey +9 more

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

New England Journal of Medicine(2001)10.1056/nejmoa011161

N/A

1.3DataRank · unranked

7453 citations

Mark E. Cooper, Dick de Zeeuw, William F. Keane, William E. Mitch, Hans-Henrik Parving +7 more

Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease

Annals of Internal Medicine(2024)10.7326/m23-3236

N/A

1.2DataRank · unranked

54 citations

Lesley A. Inker, Hocine Tighiouart, Charles E. McCulloch, Ogechi M. Adingwupu, Tom Greene +14 more

Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage

Journal of Cardiovascular Pharmacology(2006)10.1097/00005344-200606001-00009

N/A

0.728DataRank · unranked

127 citations

Robert H. Henning, Richard P.E. van Dokkum, Dick de Zeeuw, Peter Ochodnicky

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Kidney International(2020)10.1016/j.kint.2020.07.013

N/A

0.718DataRank · unranked

119 citations

Rajiv Agarwal, William G. Herrington, Hiddo J.L. Heerspink, Johannes F.E. Mann, Shahnaz Shahinfar +76 more

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00172-3

N/A

0.701DataRank · unranked

106 citations

Zeinab Bidel, Dexter Canoy, Emma Copland, Derrick Bennett, Abbas Dehghan +95 more

Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

Journal of the American Heart Association(2022)10.1161/jaha.121.025045

N/A

0.578DataRank · unranked

10 citations

Clare Arnott, Hiddo J.L. Heerspink, Qiang Li MBiostat, Christopher P. Cannon, David C. Wheeler +16 more

Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure

JACC Heart Failure(2022)10.1016/j.jchf.2022.03.004

N/A

0.434DataRank · unranked

17 citations

Jeroen V. Koomen, Donald E. Kohan, John J.V. McMurray, George L. Bakris, Ricardo Correa‐Rotter +11 more

Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome

Nephrology Dialysis Transplantation(2016)10.1093/ndt/gfv429

N/A

0.434DataRank · unranked

17 citations

Dick de Zeeuw, Frank Arjan Holtkamp, David Kenneth Packham, Hiddo J. L. Heerspink, Tobias Felix Kröpelin

Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial

Diabetes Obesity and Metabolism(2020)10.1111/dom.14252

N/A

0DataRank · unranked

21 citations

Jasper Stevens, George L. Bakris, Ricardo Correa‐Rotter, Fan Fan Hou, Dalane W. Kitzman +9 more

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes

Diabetes Obesity and Metabolism(2020)10.1111/dom.14226

N/A

0DataRank · unranked

78 citations

Clare Arnott, Vlado Perkovic, Gemma A. Figtree, Dick de Zeeuw, Greg Fulcher +8 more

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Kidney International(2020)10.1016/j.kint.2020.10.042

N/A

0DataRank · unranked

160 citations

Meg Jardine, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan +15 more

Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study

European Heart Journal(2023)10.1093/eurheartj/ehac825

N/A

0DataRank · unranked

32 citations

Juan Jesús Carrero, Kunihiro Matsushita, Yingying Sang, Shoshana H. Ballew, Morgan E. Grams +43 more

Dick de Zeeuw

Indexed papers

Top data-sharing exemplar

Papers